key: cord-0807773-68ecq55t authors: Wang, Yujia; Chen, Huanxiong; Zhang, Jiajun; Lam, Tsz-ping; Hung, A.L.H.; Cheng, J.C.Y.; Lee, W.Y.W. title: Potential Muscle-Related Biomarkers in Predicting Curve Progression to the Surgical Threshold in Adolescent Idiopathic Scoliosis—A Pilot Proteomic Study Comparing Four Non-Progressive vs. Four Progressive Patients vs. A Control Cohort date: 2021-10-25 journal: J Clin Med DOI: 10.3390/jcm10214927 sha: 584a1a60a65c2c95715722d5d1426d9633f71ffd doc_id: 807773 cord_uid: 68ecq55t Previous studies have reported abnormal muscle morphology and functions in patients with adolescent idiopathic scoliosis (AIS). To answer whether such abnormalities could be reflected in their circulation and their clinical implication for predicting curve progression to the surgical threshold, this preliminary study explored the presence of baseline muscle-related proteins and their association with curve progression. Plasma samples were collected at the first clinical visit for AIS, with patients divided into non-progressive or progressive groups (N = four and four) according to their Cobb angle in six-year follow-ups, with age- and sex-matched healthy subjects (N = 50). Then, the samples were subjected to isobaric tags for relative and absolute quantitation (iTRAQ) for global comparison of untargeted protein expression. Seventy-one differentially expressed proteins (DEPs) were found elevated in progressive AIS. Functional analysis showed that 18 of these are expressed in muscles and play an essential role in muscle activities. Among the muscle-related DEPs, α-actin had the highest fold change in progressive/non-progressive groups. This preliminary study firstly suggested higher circulating levels of muscle structural proteins in progressive AIS, indicating the likelihood of structural damage at the microscopic level and its association with progression to the surgical threshold. Further studies with larger sample sizes are warranted to validate these novel candidates for early diagnosis and predicting progression. Adolescent idiopathic scoliosis (AIS) is the most common type of three-dimensional structural deformity occurring during the puberty growth period, with a prevalence of 1~4% worldwide. AIS is more prevalent in girls than in boys [1] . For example, a five-year idiopathic scoliosis screening program of 255,875 children aged 11~14 years old in Japan reported that the prevalent ratio of girls to boys was 11:1 [2] . Our local scoliosis study on 115,190 fifth grade children indicated that the prevalence ratio of girls to boys with a Cobb angle ≥10 • was 2.7 by the age of 19 years, and the ratio increased to 4.5 and 8.1 with a Cobb angle ≥20 • and ≥40 • , respectively [3] . Unlike congenital, neuromuscular, and other types of scoliosis, the etiopathogenesis of AIS is largely unknown [1] . Bracing is an evidencebased effective treatment for patients with a Cobb angle ≥20 • by means of preventing curve progression [4] . However, wearing braces could cause a negative cosmetic appearance, poor self-esteem, and functional discomfort [5] , resulting in insufficient wearing time and thus affecting the effectiveness of this treatment. Those that develop a Cobb angle of major curve >40~45 • in the thoracolumbar region, or >50 • in the thoracic region, might accept invasive surgery to correct the anatomical deformation and to reduce the risk of further progression during adulthood. However, the potential complications of surgery, including partial or complete loss of neurological function, infection, implant failure or pseudoarthrosis, recurrence, or additional deformity, should be carefully taken into consideration [1] . Current understanding of the etiopathogenesis is limited. Investigation on unexplored areas is worthwhile to develop more effective prognostication and treatment. AIS patients have been reported to have weaker muscle strength than healthy subjects of a similar age and sex [6, 7] . Decreased respiratory muscle strength in patients with AIS has been described in pulmonary function studies [6, 8] . The posterior paraspinal muscles, including the multifidus and erector spinal muscle, provide dynamic stability to the spinal column [9] , and its imbalance has been postulated to contribute to the initiation and/or progression of spinal deformity in AIS [10, 11] . Previous studies have reported abnormal and asymmetric muscle phenotypes in concave and convex side paraspinal muscles of AIS patients, including electromyography (EMG) activities, muscle volume, muscle fiber types, and fatty and fibrosis infiltration [12] [13] [14] [15] [16] . Additionally, one recent study demonstrated a significantly lower density of activated satellite cells for fiber type I in AIS patients when compared to non-scoliosis controls, and the curve severity appeared to be associated with the density of satellite cells and other histological parameters such as cross-sectional areas of muscle fiber and myonuclear density [17] . Collectively, these findings suggest that patients with AIS have generalized muscle dysfunction, which is potentially associated with the curve severity. Until now, whether muscle abnormalities could be a predictive value for AIS onset or curve progression remained unexplored. In AIS, the current studies on paraspinal muscles rely heavily on muscle biopsies, which is a major research hurdle due to ethical concerns and the scarcity of muscle biopsies from healthy control subjects or AIS patients with mild curvature for fair comparison. Thus, less invasive tests are widely used to reveal muscle-related changes at earlier time points and for longitudinal study. Blood samples are a surrogate for systemic phenotype research, which allows for biomarker discovery. Currently, the advancement in "omics" research enables researchers to quantify a large amount of proteins/peptides and metabolites in the circulation in a non-targeted and unbiased manner, resulting in identification of numerous AIS-related predictive and prognostic biomarkers [18] . A recent metabolomics study that performed UPLC/QTOF-MS (ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry) analysis revealed differential serum lipid metabolism profiles in patients with AIS [19] . This study suggested disrupted glycerophospholipid, glycerolipid, and fatty acid metabolism in AIS patients when compared to age-matched healthy controls, and provided a list of metabolites for diagnostic biomarkers. Another two proteomic studies described the differential circulating proteomes in AIS. Shen et al. [20] compared the plasma samples derived from four AIS patients and four healthy controls using 10-plex tandem mass tag (TMT)-based quantitative MS analysis. They identified several proteins correlating with the differential gut microbiota species in AIS patients. Makino et al. [21] employed two-dimensional fluorescence difference gel electrophoresis (2D-DIGE) quantitation followed by an MS-based proteins identification strategy to compare pooled plasma samples from five severe AIS and five non-AIS control subjects, revealing the association between vitamin D binding protein and coagulationrelated proteins with AIS pathogenesis. However, these studies did not step further to explore the link between the acquired proteomic data and the risk of curve progression in AIS, specifically exploring biomarkers with respect to muscles. Therefore, the current study aimed to compare proteomic profiles among healthy girls and AIS subjects with either remaining curvature or progressing into severe cases, further providing a candidate list of muscle-related DEPs for functional and clinical validation. In this study, we aimed to (1) conduct a quantitative proteomic study screening the plasma samples from healthy controls and AIS patients, who were further divided into nonprogressive and progressive subgroups regarding their curve progression in a longitudinal follow-up; (2) compare the proteomic profiles among these three groups and filter out a list of candidate muscle-related proteins. As referred by the local population-based School Scoliosis Screening Service, students of the fifth grade or above with a maximal Cobb angle of ≥20 • were referred to our scoliosis special clinic [3] . As the prevalence of AIS is likely linked to sex and there is a higher risk of curve progression in girls, female subjects with AIS with a maximal Cobb angle of <30 • at their first clinical visit were recruited from our scoliosis clinic. Patients with other types of scoliosis with known causes or with congenital deformities, neuromuscular diseases, autoimmune disorders, endocrine disturbances, or medical conditions that affect the bone metabolism were excluded, as previously reported [22] . Non-progressive subjects prescribed with bracing or any other treatment that might interfere with curve progression during the follow-up were excluded. Blood samples and clinical data from the CAL cohort (NCT01103115) were used. The Cobb angle of a major curve was measured via standard standing posterior-anterior radiography of the whole spine at the first visit and at six-month intervals for six years (reaching skeletal maturity). All of the subjects were regularly followed, observed, and/or treated with bracing or surgical correction according to standard clinical practice (CREC Reference Number: 2009.491-T). Four subjects with curve progression that increased less than 6 • in the follow-up period were defined as the non-progressive (NP) group [23] , and four subjects that had reached the surgical threshold (≥45 • ) at any time point within the follow-up period were defined as the progressive (P) group. The classification criteria for the NP and P groups are illustrated in Figure 1a . Basic anthropometric data were measured with standardized methodology. Tanner staging and age at menarche were recorded. The body composition parameters were determined via bioelectrical impedance analysis (BIA, InBody 720, Biospace, Seoul, Korea). Handgrip strength was assessed with portable dynamometers (Nakamura Scientific Co., Ltd., Tokyo, Japan) three times using the dominant and non-dominant hands, and the mean of the three measurements was calculated. A total of 50 age-matched healthy Chinese girls were recruited randomly from local secondary schools to serve as the control (CTRL) group. Clinical examination was carried out by experienced orthopedic surgeons to exclude spinal deformities. The basic information for the CTRL, AIS NP, and AIS P groups is described in Table 1 . A total of 50 age-matched healthy Chinese girls were recruited randomly from local secondary schools to serve as the control (CTRL) group. Clinical examination was carried out by experienced orthopedic surgeons to exclude spinal deformities. The basic information for the CTRL, AIS NP, and AIS P groups is described in Table 1 . Peripheral venous blood samples (2 mL) were collected from the participants' arms at their first visit to our scoliosis special clinic. The blood was centrifuged at 4 • C, 3000× g for 10 min. The plasma were aliquoted to minimize the freeze-thaw cycle and stored at −80 • C for further analysis. Isobaric tags for relative and absolute quantitation (iTRAQ)-based [24] proteomic analysis allows relative quantitation, comparing the proteomic profiles of plasma from three groups. Considering the limitation of the maximal eight samples for one 8-plex analysis and the sample sizes of the designed comparison groups (CTRL: N = 50; NP: N = 4; P: N = 4), the strategy of groupwise pooling followed by technical duplicates was adopted ( Figure 1b ). An equal volume (300 µL) of each plasma sample within each group was pooled into one mixture and further divided into two duplicates, resulting in six plasma samples (CTRL_1, CTRL_2, NP_1, NP_2, P_1, and P_2). The duplicates in this study allowed for a decrease in the variance due to the technical error of the experimental technique. High abundance protein depletion was carried out with a ProteoMiner Protein Enrichment Kit (Cat. # 163-3007; Bio-Rad laboratories, Hercules, CA, USA) according to the manufacturer's instructions. The proteins were dissolved in lysis buffer consisting of 8 M urea for denaturation afterwards. For cysteine alkylation, protein lysis was further subjected to 10 mM dithiothreitol (DTT, Cat. #10197777001, Sigma-Aldrich, Burlington, MA, USA) with incubation at 57 • C for 45 min, followed by 10 mM iodoacetamide (IAM, Cat. #I1149-5G, Sigma-Aldrich, Burlington, MA, USA) and incubation at room temperature in the dark for 1 h. A Bradford assay was used to determine the total protein concentration, for which 50 µg of protein of each sample was diluted four times with 100 mM triethylammonium bicarbonate (TEAB, Cat. #90114, Thermo Fisher Scientific, Waltham, MA, USA). Then, the protein solution was subjected to protein digestion with Trypsin Gold (Cat. #V5117; Promega, Madison, WI, USA). Trypsin Gold was added at a 1:40 (w/w) enzyme/protein ratio for further incubation at 37 • C for 18 h. HCl was added to a final concentration of 50 mM to stop the tryptic digestion. After trypsin digestion, the peptides were desalted with a Strata X C18 column (Phenomenex, Torrance, CA, USA) according to the manufacturer's protocol, and then vacuum-dried. The digested peptides from 50 µg of protein were dissolved in 30 µL of 0.5 M TEAB and subjected to peptide labeling with an iTRAQ Reagent 8-plex Kit (SCIEX, Framingham, MA, USA) according to the manufacturer's instructions [25]: 113 and 114 for the CTRL group, 116 and 117 for the NP group, and 119 and 121 for the P group. The labeled peptides were combined and desalted with a Strata X C18 column followed by vacuumdrying. The peptides were subjected to a Shimadzu LC-20AB high-performance liquid chromatography (HPLC) pump system (Shimadzu, Kyoto, Japan) coupled with a high pH reversed-phase (RP) column to separate into 20 fractions. The following gradient was used for fractionation. The peptides were reconstituted with buffer A (5% acetonitrile (Cat. #900667-4 × 4L, Sigma-Aldrich, Burlington, MA, USA), 95% H 2 O, pH 9.8) to 2 mL and loaded onto a column containing 5 µm of particles (Phenomenex, Torrance, CA, USA). The peptides were separated at a flow rate of 1 mL/min with a gradient of 5% buffer B (5% H 2 O, 95% acetonitrile, pH 9.8) for 10 min, 5~35% buffer B for 40 min, and 35~95% buffer B for 1 min. The system was then maintained in 95% buffer B for 3 min and decreased to 5% within 1 min, before equilibrating with 5% buffer B for 10 min. Elution was monitored by measuring the absorbance at 214 nm, and fractions were collected every 1 min. The eluted peptides were pooled as 20 fractions and vacuum-dried. Each fraction was resuspended in 2% acetonitrile and 0.1% formic acid (Cat. #33015-500ML, Sigma-Aldrich, Burlington, MA, USA), and centrifuged at 20,000× g for 10 min. The supernatant was subjected to the following HPLC-MS analysis. Each fraction was loaded onto a C18 trap column using a LC-20AD nano-HPLC instrument (Shimadzu, Kyoto, Japan) by an autosampler. Then, the peptides were eluted from the trap column and separated by an analytical C18 column (inner diameter of 75 µm) packed in-house, and then subjected to MS analysis with a TripleTOF 5600 System (SCIEX, Framingham, MA, USA) equipped with a Nanospray III source (SCIEX, Framingham, MA, USA). The following gradient was used for elution of the peptides for MS analysis: buffers A and B for elution were 2% acetonitrile with 0.1% formic acid, and 98% acetonitrile with 0.1% formic acid, respectively. The gradient was run at 300 nL/min, starting from 8~35% of buffer B for 35 min, then up to 60% for 5 min, maintained at 80% B for 5 min, and finally returned to 5% for 0.1 min and equilibrated for 10 min. For the MS setting, the high-sensitivity mode was used for the whole data acquisition. The accumulation time for MS1 was 250 ms, and the mass ranges were from 350 to 1500 Da. Based on the intensity in the MS1 survey, as many as 30 product ion scans were collected if exceeding a threshold of 120 counts/s and with charge-state 2 + to 5 +, dynamic exclusion was set for 1/2 of the peak width (12 s). For iTRAQ data acquisition, the collision energy was adjusted to all precursor ions for collision-induced dissociation, and the Q2 transmission window for 100 Da was 100%. The raw MS/MS data were converted into MGF format by the ProteoWizard tool msConvert, and the exported files were searched using Mascot version 2.3.02 against the selected database Swissprot (Homo_sapiens, 201704). The fragment and peptide mass tolerance were set at 0.1 and 0.05 Da, respectively. The variable modifications were Oxidation (M) and iTRAQ8plex (Y), while the fixed modifications were Carbamidomethyl (C), iTRAQ8plex (N-term), and iTRAQ8plex (K). One missed cleavage was allowed. The false discovery rate (FDR) at 1%, which was based on the picked protein FDR strategy [26] , was used for cut-off. Automated software IQuant Protein Quantification [27] was used to analyze the labeled peptides with isobaric tags. In this project, we set NP_1/CTRL_1, NP_2/CTRL_1, NP_1/CTRL_2, NP_2/CTRL_2, P_1/CTRL_1, P_1/CTRL_2, P_2/CTRL_1, P_2/CTRL_2, P_1/NP_1, P_1/NP_2, P_2/NP_1, and P_2/NP_2 as the comparison groups. The mean ratio of the protein expression in the pairwise comparison groups was calculated. For example, the mean ratio of NP vs. CTRL = (NP_1/CTRL_1 + NP_1/CTRL_2 + NP_2/CTRL_1 + NP_2/CTRL_2)/4. A protein with a mean ratio ≤0.83 or ≥1.2, a p-value < 0.05 by an independent t-test was considered as differentially expressed protein (DEP). A Venn diagram for overlapping analysis was performed using Venny v2.1 [28] . The functions of the DEPs were analyzed using Protein Analysis Through Evolutionary Relationships (PANTHER) v15.0 [29] to demonstrate their Gene Ontology (GO) profiles. Detailed GO term descriptions at the level of DIRECT were obtained using the Database for Annotation, Visualization, and Integrated Discovery (DAVID) v6.8 [30] . A protein-protein interaction (PPI) network of the DEPs was constructed using the online Search Tool for the Retrieval of Interacting Genes (STRING) database [31] . The minimum required interaction score was set to medium confidence (0.4). The PPI results were exported and subjected to Cytoscape v3.7.2 for visualization. The other results were visualized using PRISM v7.03. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE [32] partner repository with the dataset identifier PXD023915. All results are presented as mean ± SD. Independent t-test, Kruskal-Wallis tests, or Mann-Whitney U tests were used for comparison studies. Statistical analysis was performed with SPSS 22. A p-value of <0.05 was considered statistically significant. Among the 110 subjects in the dataset, a total of eight age-matched AIS subjects with a maximal Cobb angle of <30 • at the first visit (baseline) without any prior treatment and who were skeletally immature (years since menarche of